276 related articles for article (PubMed ID: 21132264)
21. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin].
Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689
[TBL] [Abstract][Full Text] [Related]
22. Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
Bae-Jump VL; Zhou C; Boggess JF; Gehrig PA
Cancer; 2009 Sep; 115(17):3887-96. PubMed ID: 19484784
[TBL] [Abstract][Full Text] [Related]
23. Sodium dichloroacetate (DCA) reduces apoptosis in colorectal tumor hypoxia.
Shahrzad S; Lacombe K; Adamcic U; Minhas K; Coomber BL
Cancer Lett; 2010 Nov; 297(1):75-83. PubMed ID: 20537792
[TBL] [Abstract][Full Text] [Related]
24. Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis.
You BR; Moon HJ; Han YH; Park WH
Food Chem Toxicol; 2010 May; 48(5):1334-40. PubMed ID: 20197077
[TBL] [Abstract][Full Text] [Related]
25. Dichloroacetate induces apoptosis in endometrial cancer cells.
Wong JY; Huggins GS; Debidda M; Munshi NC; De Vivo I
Gynecol Oncol; 2008 Jun; 109(3):394-402. PubMed ID: 18423823
[TBL] [Abstract][Full Text] [Related]
26. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance spectroscopic investigation of mitochondrial fuel metabolism and energetics in cultured human fibroblasts: effects of pyruvate dehydrogenase complex deficiency and dichloroacetate.
Simpson NE; Han Z; Berendzen KM; Sweeney CA; Oca-Cossio JA; Constantinidis I; Stacpoole PW
Mol Genet Metab; 2006; 89(1-2):97-105. PubMed ID: 16765624
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells.
Loar P; Wahl H; Kshirsagar M; Gossner G; Griffith K; Liu JR
Am J Obstet Gynecol; 2010 Apr; 202(4):371.e1-8. PubMed ID: 20138251
[TBL] [Abstract][Full Text] [Related]
29. [Comparative study of that synergistic effect of cisplatin combined with compound herbal medicinal prescription for tonic quality and activating blood circulation is on SKOV3 cell proliferation and apoptosis].
Suo YP; Wang BY; Hong Z; Yin RT; Wang DQ; Peng ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):542-6. PubMed ID: 16909597
[TBL] [Abstract][Full Text] [Related]
30. Shrimp anti-lipopolysaccharide factor peptide enhances the antitumor activity of cisplatin in vitro and inhibits HeLa cells growth in nude mice.
Lin MC; Lin SB; Chen JC; Hui CF; Chen JY
Peptides; 2010 Jun; 31(6):1019-25. PubMed ID: 20214941
[TBL] [Abstract][Full Text] [Related]
31. Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs.
Heshe D; Hoogestraat S; Brauckmann C; Karst U; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2011 Mar; 67(3):647-55. PubMed ID: 20502900
[TBL] [Abstract][Full Text] [Related]
32. Tea polyphenols modulate antioxidant redox system on cisplatin-induced reactive oxygen species generation in a human breast cancer cell.
Periasamy VS; Alshatwi AA
Basic Clin Pharmacol Toxicol; 2013 Jun; 112(6):374-84. PubMed ID: 23145928
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
[TBL] [Abstract][Full Text] [Related]
34. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W
Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946
[TBL] [Abstract][Full Text] [Related]
35. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
[TBL] [Abstract][Full Text] [Related]
36. Dichloroacetate at therapeutic concentration alters glucose metabolism and induces regulatory T-cell differentiation in alloreactive human lymphocytes.
Eleftheriadis T; Pissas G; Karioti A; Antoniadi G; Antoniadis N; Liakopoulos V; Stefanidis I
J Basic Clin Physiol Pharmacol; 2013; 24(4):271-6. PubMed ID: 23612652
[TBL] [Abstract][Full Text] [Related]
37. [Effect of chemotherapy with cisplatin and rapamycin against Hep-2 cells in vitro].
Lei WB; Jia T; Su ZZ; Wen WP; Zhu XL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1838-41. PubMed ID: 18971185
[TBL] [Abstract][Full Text] [Related]
38. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
Li D; Williams JI; Pietras RJ
Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
[TBL] [Abstract][Full Text] [Related]
39. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells.
Gottschalk S; Anderson N; Hainz C; Eckhardt SG; Serkova NJ
Clin Cancer Res; 2004 Oct; 10(19):6661-8. PubMed ID: 15475456
[TBL] [Abstract][Full Text] [Related]
40. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
